Launching
of Tanovea-CA1, the FDA approved animal drug for treating canine lymphoma is
indeed a breakthrough in pet
cancer therapeutics market. Synonymous with lymphosarcoma, this detrimental
disease is the most common type of cancer affecting dogs. Center for Veterinary
Medicine, a subsidiary of U.S Food and Administration has recently announced a
partial approval to this groundbreaking anti-cancer drug and depending upon the
effectiveness, market experts anticipates its full approval within few years. A
Colorado State University startup, VetDC Inc., is commercially merchandizing
these drugs and are presently available in the U.S. market by licensed
veterinarians. Reportedly, TANOVEA-CA1 is the only effective animal drug
available in pet cancer therapeutics market for the treatment of lymphoma.
Request for a sample of
this research report - https://www.gminsights.com/request-sample/detail/2017
In
veterinary oncology, chemotherapy is the most recognized therapeutic model that
is extensively deployed as one of the most relatively effective methodologies
of treatment. In fact, in 2016, chemotherapy held the largest share of the
overall pet cancer therapeutics industry. However, as stated by a reputed pet
care organization, the goal of chemotherapy treatment in veterinary patients is
slightly different from that of human patients. In case of pet cancer
treatment, outgrowth of cancer cells is tried to limit as much as possible but
not at the cost of their quality of life. However, it has been noticed that
cats and dogs respond to chemotherapy much better than humans, which again is
pushing pet cancer therapeutics market from chemotherapy.
Browse
key industry insights spread across 95 pages with 80 market data tables & 9
figures & charts from this 2017 report Pet
Cancer Therapeutics Market in detail along with the table of contents at:
Funding impacting the
pet cancer therapeutics industry dynamics:
Blue
Buffalo Foundation and The Petco Foundation have entered a partnership to
provide a grant of USD 750000 to Morris Animal Foundation. Reportedly this
grand sum of investment is an initiative taken to fund Morris Animal
Foundation’s research initiative related to osteosarcoma and other additional
studies related to pet cancer. Out of the total grant, USD 500000 is reported
to invest in the Foundation’s Osteosarcoma Initiative. Surveys depict that
osteosarcoma is a belligerent tumor that is most frequently detected in dogs.
The lumpsum grant unquestionably will bring an awareness that would result in
an enhancement in the pet cancer therapeutics industry outlook.
Make an inquiry for
purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2017
As
per a recent report put forward by Global Market Insights, Inc., Pet cancer
therapeutics market is forecast to exceed a revenue of USD 300 million by 2024,
with a projected CAGR of 10% over 2017-2024.
Some of the prominent biggies in the pet cancer therapeutics market
include Zoetis, Aratana Therapeutics Merial, AB Science, VetDC, Vetivax,
Karyopharms Verdinexor, and Regeneus. The industry is rather new and is rapidly
expanding with regards to product development and expansive pool of veterinary
patients affected with cancers. Though the fraternity till date has been
substantially dominated by leading pharmaceutical giants, pet cancer
therapeutics industry is poised to carve a profitable road map in the years
ahead with a plethora of new entrants specialized in pet cancer therapy.
Animal Healthcare Market Size
By Pharmaceuticals (Ectoparasiticides,
Endoparasiticides, Anti-inflammatories, Anti-infectives), By Vaccines (Poultry,
Cattle, Swine, Equine, Dogs, Cats, Horses), By Medicated Feed Additives(
Antibiotics, Vitamins, Amino acids, Enzymes, Antioxidants, Prebiotics and
Probiotics, Minerals), By Animal Type ( Farm Animal And Companion Animal),
Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, Poland,
Netherlands, China, Japan, India, South Korea, Australia, Brazil, Mexico, South
Africa, Saudi Arabia), Technology Development, Competitive Landscape &
Forecast, 2017 – 2024
About Global Market Insights:
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and
actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
